US Patent Issued to INSTITUT CURIE, MNEMO THERAPEUTICS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE on May 12 for "Immunotherapy targeting tumor neoantigenic peptides" (French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,926, issued on May 12, was assigned to INSTITUT CURIE (Paris), MNEMO THERAPEUTICS (Paris) and INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris).

"Immunotherapy targeting tumor neoantigenic peptides" was invented by Sebastian Amigorena (Paris), Marianne Burbage (Paris), Alexandre Houy (Vitry sur Seine, France), Marc-Henri Stern (Paris), Joshua Waterfall (Paris), Benjamin Sadacca (Paris), Antonela Merlotti Ippolito (Paris) and Yago Arribas De Sandoval (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method for selecting a tumor neoantigenic peptide wherein said method comprises: -a step of identi...